Evidence map›Paper›PMID 28827283›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Shared αβ TCR Usage in Lungs of Sarcoidosis Patients with Löfgren's Syndrome.

Angela M Mitchell, Ylva Kaiser, Michael T Falta, Daniel J Munson, Laurie G Landry, Anders Eklund, Maki Nakayama, Jill E Slansky, Johan Grunewald, Andrew P Fontenot

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. T cell receptor sequencing in autoimmunity.Journal of life sciences (Westlake Village, Calif.) · 2020
    Article
  10. Molecular profiling in sarcoidosis.Current opinion in pulmonary medicine · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Frontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Angela M MitchellDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Ylva KaiserDepartment of Medicine, Solna, Center for Molecular Medicine, Karolinska Institutet, SE-171 76 Stockholm, Sweden; and.ORCID 0000-0003-2946-8718
Michael T FaltaDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.ORCID 0000-0002-0835-6904
Daniel J MunsonDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Laurie G LandryBarbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Anders EklundDepartment of Medicine, Solna, Center for Molecular Medicine, Karolinska Institutet, SE-171 76 Stockholm, Sweden; and.
Maki NakayamaDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Jill E SlanskyDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Johan GrunewaldDepartment of Medicine, Solna, Center for Molecular Medicine, Karolinska Institutet, SE-171 76 Stockholm, Sweden; and.
Andrew P FontenotDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; andrew.fontenot@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USKarolinska Institutet · SE

Funding

Multiple Autoantigens/Multiple Epitopes of Type 1DMR01DK032083 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W · 1986 to 2025
$6.9M
PATHOGENIC T CELLS IN CHRONIC BERYLLIUM DISEASER01HL062410 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 1998 to 2017
$5.7M
Molecular Dissection of Insulin Targeting in Anti-Islet AutoimmunityR01DK099317 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI AARON W MICHELS, Maki Nakayama · 2013 to 2026
$5.3M
T cell epitopes in sarcoidosisR01HL136137 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI PALMER, BRENT E · 2017 to 2024
$4.7M
Interactions between antigen-specific effector and regulatory T cells in beryllium-induced diseaseR01ES025534 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2016 to 2020
$2.1M
Patient-Oriented Research in Immunologic Lung Disease.K24HL102245 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2010 to 2020
$1.4M
NHLBI NIH HHS K24 HL102245NHLBI NIH HHS R01 HL062410NHLBI NIH HHS R01 HL136137NIDDK NIH HHS R01 DK032083NIDDK NIH HHS R01 DK099317NIEHS NIH HHS R01 ES025534
6 · The paper itself

Abstract

Sarcoidosis is a granulomatous disease that primarily affects the lungs and is characterized by an accumulation of CD4

Indexed as

Acute DiseaseAdultAgedBronchoalveolar Lavage FluidCD4-Positive T-LymphocytesFemaleHigh-Throughput Nucleotide SequencingHLA-DRB1 ChainsHumansLungMaleMiddle AgedReceptors, Antigen, T-Cell, alpha-betaReceptors, Tumor Necrosis Factor, Member 25Sarcoidosis, PulmonaryHLA-DRB1*03:01 antigenHLA-DRB1 ChainsReceptors, Antigen, T-Cell, alpha-betaReceptors, Tumor Necrosis Factor, Member 25TNFRSF25 protein, human

Identifiers

PMID28827283
PMCPMC5675165
OpenAlexW2749371223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.